Genactis

Genactis

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Genactis is a private, revenue-generating services company founded in 2018, headquartered in Munich, Germany. It operates in the healthcare insights sector, offering two main services: senior-led primary market research for pharmaceutical and biotech clients, and access to its proprietary Genactis Health Panel for fieldwork. The company differentiates itself through a boutique, strategic approach, deep healthcare expertise, and a quality-controlled, verified global physician network, enabling rapid, actionable insights for commercial decision-making.

CRISPRSynthetic Biology

Technology Platform

Genactis Health Panel: A proprietary, verified global network of over 18,000 actively practicing physicians across 40 countries and 43 specialties, used for healthcare market research fieldwork.

Opportunities

Growing demand for high-quality, specialist physician insights driven by the rise of complex specialty therapeutics.
Strong EU panel coverage provides a competitive edge in a fragmented but critical market.
Potential to expand service offerings into adjacent areas like real-world evidence (RWE) or digital health advisory.

Risk Factors

Revenue is vulnerable to cuts in pharmaceutical marketing and research budgets.
Core asset, the physician panel, faces risks of fatigue, attrition, and quality control challenges across diverse geographies.
Intense competition from larger full-service research firms and niche boutiques requires constant demonstration of superior value.

Competitive Landscape

Competes with large global market research firms (e.g., IQVIA) and specialized healthcare insights boutiques. Differentiation is based on a boutique, senior-led strategic approach, a quality-controlled proprietary physician panel, and strong European coverage. Competes on insight quality and speed rather than lowest cost.